NXGL
NEXGEL, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$5.80
+3.76%Year over year
Reported trailing growth
- Revenue
- +3.4%
- EBITDA
- +6.5%
- EBIT
- -77.6%
- EPS
- —
- Free cash flow
- -9.6%
- Operating cash flow
- -11.2%
Forward estimates
Based on analyst estimates
- Revenue
- -56.4%
- EBITDA
- +174.1%
- EPS
- +98.6%
Three-year CAGR
- Revenue
- +77.3%
- EBITDA
- +27.0%
- EBIT
- +5.7%
- Net income
- +8.6%
- EPS
- +24.0%
- Free cash flow
- +68.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026